Skip to main content

Integra Lifesciences Holdings

Integra LifeSciences Holdings Corporation is an American medical device manufacturer specializing in neurosurgery, regenerative tissue technologies, and surgical instrumentation. The company operates through two main business segments: Codman Specialty Surgical, manufacturing neurosurgical implants, dural repair membranes, and surgical instruments, and Tissue Technologies, producing regenerative skin and wound care matrixes under brands like MicroMatrix. Principal revenues derive from direct equipment sales of surgical devices, regenerative implants, and tissue matrixes to hospital surgical departments. Core end markets encompass neurosurgeons, plastic reconstructive surgeons, orthopedic wound specialists, and surgical hospitals globally. Integra LifeSciences holds a market-leading global position in neurosurgical dural grafts and regenerative tissue matrix products. The corporation is headquartered in Princeton, New Jersey, and its common stock trades on the Nasdaq Global Select Market.

4 of the funds FundTelligence covers report a position in Integra Lifesciences Holdings.

Legal name
INTEGRA LIFESCIENCES HOLDINGS
Sector
Health Care
Country
United States
Funds holding it
4

Funds holding Integra Lifesciences Holdings

Loading...